Confident Investing Starts With TipRanks Premium

Angiex Inc

c/o LabCentral 610, 610 Main Street Cambridge, MA 02139, UShttps://angiex.com/Therapeutics

Angiex Inc. is a privately held biotech company focused on exploiting newly discovered biological transport mechanisms to develop drugs with revolutionary power over cancer. Based in Cambridge, Mass., the company is developing a portfolio of Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) that release therapeutic payloads directly into the nucleus of cells in the tumor environment, enhancing the efficacy and therapeutic margin of conventional ADCs.

Leadership & Board

Current Number of Employees: 10
Current LinkedIn Followers: 1,695

Latest Estimated Valuation

Estimated Valuation: ―
Total Amount Raised: $31M
Total Funding Rounds: 1
Latest Funding Amount: $31M
Latest Funding Round: Investment
Post-Money Valuation: ―

Employee Trend

Angiex Inc had 10 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.

10Latest Employee Count

0(0.00%)Week-Over-Week Change

Social Trend

Angiex Inc had 1,695 followers as of October 12, 2026. The number of followers increased by 3 (0.18%) week-over-week.

1,695Latest Followers Count

3(0.18%)Week-Over-Week Change

Funding Round

Funding Date	Funding Round	Amount Raised	Post-Money Valuation
Nov 17, 2025	Investment	$31.00M	―

Similar Companies

A snapshot of private companies similar to Angiex Inc, helping you discover and navigate related company profiles.

Advanced NanoTherapies Inc

Ractigen Therapeutics

Related News and Analysis

Angiex Integrates Natera’s Signatera Assay Into Phase 1 Trial of AGX101

Angiex Integrates Natera’s Signatera Assay Into Phase 1 Trial of AGX101

According to a recent LinkedIn post from Angiex Inc, the company is collaborating with Natera to incorporate the Signatera molecular residual disease test into its Phase 1 clinical trial of

2M ago

Angiex Highlights Long-Term Development of Novel Nuclear-Delivered ADC AGX101

Angiex Highlights Long-Term Development of Novel Nuclear-Delivered ADC AGX101

According to a recent LinkedIn post from Angiex Inc, the company traces its lead program AGX101 back to 17 years of scientific work on the TM4SF1 target. The post outlines

2M ago

Angiex Highlights TM4SF1-Targeted ADC Strategy in Solid Tumor Oncology

Angiex Highlights TM4SF1-Targeted ADC Strategy in Solid Tumor Oncology

According to a recent LinkedIn post from Angiex Inc, the company’s origin centers on a specific biological insight rather than a preexisting drug program or market trend. The post highlights

3M ago

Salt Security Flags Rising Agentic AI Risks as Enterprises Struggle to Control Autonomous Systems

Salt Security Flags Rising Agentic AI Risks as Enterprises Struggle to Control Autonomous Systems

New updates have been reported about Salt Security. Salt Security has released its State of Agentic AI and API Security 2H 2026 report, positioning the company at the center of

10m ago

Pudu Robotics’ BG1 Wins Dual ISSA Honors, Underscoring Global Cleaning Robotics Lead

Pudu Robotics’ BG1 Wins Dual ISSA Honors, Underscoring Global Cleaning Robotics Lead

New updates have been reported about Pudu Robotics. Pudu Robotics has strengthened its position in commercial cleaning robotics with its PUDU BG1 Series earning two ISSA awards in South Korea

10m ago

Joyful Health Expands AI-Driven Denial Management Into Full Lifecycle RCM Solution

Joyful Health Expands AI-Driven Denial Management Into Full Lifecycle RCM Solution

New updates have been reported about Joyful Health. Joyful Health is broadening its role as a revenue cycle management partner with the launch of its Denial Prevention, Intelligence & Recovery

10m ago

Abram Scientific Secures DARPA Funding to Advance Portable Coagulation Diagnostics for Trauma Care

Abram Scientific Secures DARPA Funding to Advance Portable Coagulation Diagnostics for Trauma Care

New updates have been reported about Abram Scientific. Abram Scientific has secured a new Defense Advanced Research Projects Agency (DARPA) contract worth up to $8.3 million to accelerate development of

10m ago

PetScreening Leadership Named GlobeSt Multifamily Influencers, Underscoring Sector Impact

PetScreening Leadership Named GlobeSt Multifamily Influencers, Underscoring Sector Impact

New updates have been reported about PetScreening. PetScreening is tightening its position at the center of pet policy management in rental housing as three senior leaders are named 2026 Multifamily

10m ago

DesignVerse Explores AI-Assisted Delivery Themes at SF Tech Week

DesignVerse Explores AI-Assisted Delivery Themes at SF Tech Week

A LinkedIn post from DesignVerse describes an SF Tech Week event hosted with a16z that explored three pillars of AI-assisted delivery: control, cost, and context. The post outlines discussion prompts

17m ago

Bloomreach Showcases Data-Driven CRM Capabilities With Loomi

Bloomreach Showcases Data-Driven CRM Capabilities With Loomi

According to a recent LinkedIn post from Bloomreach, the company is spotlighting how CRM and loyalty specialist Sophie Shelley has leveraged its Loomi technology to deepen analysis of customer metrics.

17m ago